Page last updated: 2024-08-17

levodopa and dihydroergotoxine

levodopa has been researched along with dihydroergotoxine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (77.78)	18.7374
1990's	2 (22.22)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dobrew, D; Milanow, S; Zonew, I	1
Mills, E; Schanberg, SM; Tadepalli, AS	1
Bruggi, P; Martignoni, E; Nappi, G; Pacchetti, C; Pedevilla, M; Sibilla, L	1
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG	1
Ermini, M; Finch, CE; Flurkey, K; Randall, PK; Sinha, YN	1
Boghen, M; Ferrari, C; Mailland, F; Paracchi, A; Rampini, P	1
Fisman, M	1
Benco, R; Ferrari, C; Mailland, F; Rampini, P; Romussi, M	1
Bardin, PG; Battistin, L; Ferro-Milone, F; Ravenna, C; Reboldi, G; Toso, V	1

Reviews

2 review(s) available for levodopa and dihydroergotoxine

Article	Year
Medical treatment of pituitary adenomas: effects on tumor growth. Journal of endocrinological investigation, 1985, Volume: 8, Issue:3 Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed	1985
Clinical pharmacology of senile dementia. Progress in neuro-psychopharmacology, 1981, Volume: 5, Issue:5-6 Topics: Aged; Aging; Anticoagulants; Arginine Vasopressin; Brain; Choline; Dementia; Dihydroergotoxine; Free Radicals; Glucose; Humans; Levodopa; Neurotransmitter Agents; Vasodilator Agents; Xanthinol Niacinate	1981

Trials

2 trial(s) available for levodopa and dihydroergotoxine

Article	Year
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial. Clinical neuropharmacology, 1991, Volume: 14, Issue:1 Topics: Dihydroergotoxine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Synapses; Time Factors	1991
Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomized double blind parallel group study. Acta neurologica Scandinavica, 1999, Volume: 99, Issue:1 Topics: Aged; Antiparkinson Agents; Dihydroergotoxine; Disabled Persons; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome	1999

Article

Year

Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial.

Clinical neuropharmacology, 1991, Volume: 14, Issue:1

Topics: Dihydroergotoxine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Synapses; Time Factors

1991

Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomized double blind parallel group study.

Acta neurologica Scandinavica, 1999, Volume: 99, Issue:1

Topics: Aged; Antiparkinson Agents; Dihydroergotoxine; Disabled Persons; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome

1999

Other Studies

5 other study(ies) available for levodopa and dihydroergotoxine

Article	Year
The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients. Therapia Hungarica (English edition), 1977, Volume: 25, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Diabetes Mellitus; Dihydroergotoxine; Drug Evaluation; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland, Anterior; Secretory Rate	1977
Depression and enhancement of baroreceptor pressor response in cats after intracerebroventricular injection of noradrenergic blocking agents: dependence on supracollicular areas of the brain. Circulation research, 1976, Volume: 39, Issue:5 Topics: Animals; Arterial Occlusive Diseases; Bradycardia; Carotid Artery Diseases; Cats; Decerebrate State; Depression, Chemical; Dihydroergotoxine; Dose-Response Relationship, Drug; Hemodynamics; Injections, Intraventricular; Levodopa; Norepinephrine; Phentolamine; Phenylephrine; Pressoreceptors; Stimulation, Chemical; Superior Colliculi; Sympathetic Nervous System	1976
Transient shortening of estrous cycles in aging C57BL/6J mice: effects of spontaneous pseudopregnancy, progesterone, L-dihydroxyphenylalanine, and hydergine. Biology of reproduction, 1987, Volume: 36, Issue:4 Topics: Aging; Animals; Carbidopa; Dihydroergotoxine; Estrus; Female; Levodopa; Mice; Mice, Inbred C57BL; Ovulation; Progesterone; Pseudopregnancy; Silicone Elastomers; Time Factors	1987
Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation. European journal of clinical pharmacology, 1985, Volume: 27, Issue:6 Topics: Acromegaly; Adenoma; Adult; Aged; Dihydroergotoxine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Time Factors	1985
Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions. Acta endocrinologica, 1983, Volume: 103, Issue:1 Topics: Acromegaly; Adenoma; Adolescent; Adult; Amenorrhea; Dihydroergotoxine; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Nomifensine; Pituitary Gland; Pituitary Neoplasms; Prolactin	1983